Divis Laboratories Ltd | DIVI - Los Gastos De Explotación

Precio De Mercado
6,470.00
Cambio Diario
108.50 1.71%
Mensual
8.79%
Anual
7.36%
Q2 Expectativa
6,221.55




Los Gastos De Explotación Cambio Fecha
Alaunos Therapeutics USD 1.19M 148K 2025-09
Aurobindo Pharma INR 73.37B 3.01B 2025-12
Avita Medical AUD 28.02M 1.55M 2025-12
Dianthus Therapeutics USD 69.82M 29.14M 2025-12
Divis Laboratories Ltd INR 18.32B 1.08B 2025-12
Ionis Pharmaceuticals USD 418M 101.1M 2025-12
IQVIA Holdings USD 1.69B 4.47B 2025-12
Lupin INR 52.71B 443.1M 2025-12
Moderna USD 1.54B 259M 2025-12
Organon & Co USD 906M 362M 2025-09
Revvity USD 626.22M 25.62M 2025-12
Tectonic Therapeutic USD 21.52M 374K 2025-12
Tilray USD 237.52M 17.34M 2025-09
Viatris USD 3.86B 335.7M 2025-12
Xeris Pharmaceuticals USD 69.03M 1.38M 2025-12